UBS Group’s Bird Global, Inc. Warrants each whole warrant exercisable to purchase 1/25th of a share of Class A Common Stock at an exercise price of $287.50 per share BRDS.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,742
Closed 11321
2022
Q2
$0 Buy
2,742
+10
+0.4% +$2 ﹤0.01% 11320
2022
Q1
$1K Sell
2,732
-2,036
-43% -$1.09K ﹤0.01% 10032
2021
Q4
$5K Buy
+4,768
New +$7.03K ﹤0.01% 9450

Other funds holding BRDS.WS

UBS Group's BRDS.WS Position: Q3 2022 in Review

UBS Group sold out of Bird Global, Inc. Warrants each whole warrant exercisable to purchase 1/25th of a share of Class A Common Stock at an exercise price of $287.50 per share (BRDS.WS) in Q3 2022, closing a stake of 2,742 shares.

UBS Group first reported a position in BRDS.WS in Q4 2021 and held it in 3 quarters. The position peaked at $5K in Q4 2021. 21 funds tracked by Wall St. Rank hold BRDS.WS as of Q3 2022.

  • UBS Group reported no remaining Bird Global, Inc. Warrants each whole warrant exercisable to purchase 1/25th of a share of Class A Common Stock at an exercise price of $287.50 per share position as of Q3 2022 after selling out during the quarter.
  • UBS Group sold 2,742 Bird Global, Inc. Warrants each whole warrant exercisable to purchase 1/25th of a share of Class A Common Stock at an exercise price of $287.50 per share shares in Q3 2022.
  • UBS Group first reported a position in Bird Global, Inc. Warrants each whole warrant exercisable to purchase 1/25th of a share of Class A Common Stock at an exercise price of $287.50 per share in Q4 2021 and held it in 3 quarters.
  • UBS Group's Bird Global, Inc. Warrants each whole warrant exercisable to purchase 1/25th of a share of Class A Common Stock at an exercise price of $287.50 per share position peaked at $5K in Q4 2021.
  • 21 funds tracked by Wall St. Rank held Bird Global, Inc. Warrants each whole warrant exercisable to purchase 1/25th of a share of Class A Common Stock at an exercise price of $287.50 per share as of Q3 2022.

Based on UBS Group's 13F filing for Q3 2022, filed 10 Nov 2022.